SCHEMBL588533

SCHEMBL588533

CC(Cc1nc(N2CCN(c3ccc(Cl)cc3)CC2)nc2c1SCC2)C(N)C(N)OC(=O)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ MAPT P10636 3/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ TSHR P16473 2/20 0.34
▸ CETP P11597 2/20 0.33
▸ USP2 O75604 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ DPP4 P27487 1/20 0.32
▸ CFD P00746 1/20 0.32
▸ BAP1 Q92560 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL588532 0.76 KMT2A (0.36) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
Trifluoroacetic Acid SCHEMBL2672412 0.72 GPR6 (0.36) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL4152368 0.70 CETP (0.40) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL3948728 0.69 CETP (0.42) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL2922890 0.69 ALDH1A1 (0.48) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL588576 0.69 KMT2A (0.43) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL588747 0.69 CCR1 (0.39) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL588746 0.69 CCR1 (0.39) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL588859 0.68 ALDH1A1 (0.44) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA
SCHEMBL29092505 0.68 ALDH1A1 (0.41) SMN1; SMN2MAPTCYP3A4CYP2C9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114878-B2 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-14 — — US disclosed
Send feedback